Speciality Medicines Limited (BOM:544738)
India · Delayed Price · Currency is INR 166.00
+7.65 (4.83%)
At close: Sep 11, 2026
Speciality Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 245.46 | 8.46 | 2.49 | 2.62 | 0.77 |
Cash & Short-Term Investments | 245.46 | 8.46 | 2.49 | 2.62 | 0.77 |
Cash Growth | 2802.06% | 239.81% | -4.83% | 241.00% | - |
Accounts Receivable | 265.01 | 96.05 | 107.13 | 55.06 | 25.91 |
Other Receivables | 11.52 | 7.39 | 7.31 | 7.45 | 1.64 |
Receivables | 277.44 | 103.87 | 114.76 | 62.73 | 27.55 |
Inventory | 283.17 | 173.76 | 80.31 | 45.95 | 4.83 |
Other Current Assets | 83.61 | 78.12 | 11.93 | 2.11 | 2.35 |
Total Current Assets | 889.67 | 364.21 | 209.49 | 113.4 | 35.5 |
Property, Plant & Equipment | 17.13 | 18.67 | 14.71 | 16.93 | 19.08 |
Long-Term Investments | 3.04 | 1.02 | 1 | 1 | 2.11 |
Other Intangible Assets | 0.92 | 1.02 | 0.88 | 0.73 | 0.73 |
Long-Term Deferred Tax Assets | - | - | 0.18 | - | 0.05 |
Other Long-Term Assets | 41.48 | 15.24 | 7.02 | 0.3 | 0.3 |
Total Assets | 952.23 | 400.15 | 233.27 | 132.35 | 57.76 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 119.16 | 9.71 | 24.15 | 18.02 | 11.83 |
Accrued Expenses | 1.2 | 0.35 | 1.52 | 0.53 | 0.67 |
Short-Term Debt | 3.92 | 11.95 | 17.25 | 16.91 | 11.78 |
Current Portion of Long-Term Debt | 12.32 | 12.44 | 2.88 | - | - |
Current Income Taxes Payable | 24.92 | 14.94 | 6.72 | - | 6.64 |
Other Current Liabilities | 27.29 | 16.8 | 4.9 | 12.77 | 7.4 |
Total Current Liabilities | 188.82 | 66.18 | 57.41 | 48.24 | 38.32 |
Long-Term Debt | 50.18 | 26.08 | 8.45 | 19.49 | - |
Pension & Post-Retirement Benefits | 1.02 | 1.24 | 0.6 | - | 0.12 |
Long-Term Deferred Tax Liabilities | 0.29 | 0.43 | - | - | - |
Other Long-Term Liabilities | -0 | - | - | 0.12 | - |
Total Liabilities | 240.3 | 93.93 | 66.46 | 67.84 | 38.44 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 87.86 | 64.36 | 51.17 | 38.2 | 2.1 |
Additional Paid-In Capital | 371.18 | 103.28 | 49.02 | - | 2.43 |
Retained Earnings | 252.89 | 138.58 | 66.62 | 26.31 | 14.79 |
Shareholders' Equity | 711.93 | 306.22 | 166.81 | 64.51 | 19.32 |
Total Liabilities & Equity | 952.23 | 400.15 | 233.27 | 132.35 | 57.76 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 66.42 | 50.47 | 28.58 | 36.4 | 11.78 |
Net Cash (Debt) | 179.03 | -42.01 | -26.09 | -33.78 | -11.01 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | 20.47 | -6.53 | -5.10 | -9.44 | -3.62 |
Filing Date Shares Outstanding | 8.79 | 6.44 | 6.44 | 3.82 | 3.04 |
Total Common Shares Outstanding | 8.79 | 6.44 | 5.12 | 3.82 | 3.04 |
Working Capital | 700.86 | 298.03 | 152.08 | 65.16 | -2.82 |
Book Value Per Share | 81.03 | 47.58 | 32.60 | 16.89 | 6.36 |
Tangible Book Value | 711.01 | 305.2 | 165.93 | 63.78 | 18.6 |
Tangible Book Value Per Share | 80.93 | 47.42 | 32.43 | 16.70 | 6.12 |
Land | 5.58 | 5.58 | - | - | - |
Buildings | 15.75 | 15.75 | 15.75 | 15.74 | 15.75 |
Machinery | 5.7 | 5.62 | 5.35 | 5.25 | 4.45 |